Product/Service

Contract Manufacturing: Cytotoxics

Source: Baxter Healthcare Corporation -- BioPharma Solutions
As a global parenteral drug leader with more than 75 years of experience, Baxter knows how to get your product to market with proven efficiency and reliability. Integrated, state-of-the-art resources dedicated exclusively to cytotoxic and high-potency product manufacturing ensure your molecule moves smoothly from development and clinical trials right through full-scale commercial manufacturing.

Click Here To Download:
•Product Brochure: Cytotoxic Manufacturing
•Product Brochure: Optimize Your Production Potential
•Product Brochure: Outsourcing With Baxter

Experience you can trust ...
Parenteral cytotoxic agents are among the most highly sensitive drugs to handle and produce. As a global parenteral drug leader with more than 75 years of experience, Baxter knows how to get your product to market with proven efficiency and reliability.

At our newly expanded cytotoxic manufacturing facility in Halle, Germany, all your cytotoxic parenteral needs are handled under one roof, which allows us to create highly efficient processing solutions to fit your compound. A dedicated cytotoxic focus helps ensure capacity and flexibility–critical ingredients for maintaining reliable product supply.

Lyophilization and filling capabilities:

  • Liquid and dry-powder filling
  • Clinical- and commercial-scale lyophilizers
  • Sterile crystallization
  • Lyo cycle development

Integrated support services designed to help speed your product to market, including:

  • Stability storage, validation, and documentation
  • Technology transfer
  • Analytical and microbiological services
  • Packaging/Kitting

Click Here To Download:
•Product Brochure: Cytotoxic Manufacturing
•Product Brochure: Optimize Your Production Potential
•Product Brochure: Outsourcing With Baxter